MINI FUTURE SHORT - STRYKER CORP. Stock

Certificat

DE000PC0RHY7

Delayed Deutsche Boerse AG 02:50:40 2024-05-23 am EDT
4.3 EUR -2.93% Intraday chart for MINI FUTURE SHORT - STRYKER CORP.
Current month+4.48%
1 month-13.81%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-23 4.3 -2.93%
24-05-22 4.43 -8.47%
24-05-21 4.84 -1.22%
24-05-20 4.9 +11.11%
24-05-17 4.41 -0.23%

Delayed Quote Deutsche Boerse AG

Last update May 23, 2024 at 02:50 am EDT

More quotes

Static data

Product typeKnock-Out mit Stop Loss
Buy / SellPUT
Underlying STRYKER CORPORATION
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC0RHY
ISINDE000PC0RHY7
Date issued 2023-04-04
Strike 382.3 $
Maturity Unlimited
Parity 10 : 1
Emission price 8.68
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 12.13
Lowest since issue 2

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
335.4 USD
Average target price
372.4 USD
Spread / Average Target
+11.01%
Consensus